Shire is to acquire rare disease company ViroPharma for $4.2 billion in a strategic move to boost its

Pfizer’s kidney drug Rapamune did not meet its primary endpoint in phase 3 clinical trials. The trials of

Salix Pharmacueticals has acquired specialty biopharmaceutical company, Santarus, for $2.6 billion, boosting its focus into gastrointestinal disorders. “We

Following the US FDA approval of Genentech’s Gazyva, phase 3 clinical trial results have been published showing that

The UK Government has struck a new five-year, multi-billion pricing deal with pharmaceutical companies to cap the NHS

Novartis has revealed that it may be closing its UK site in Horsham, West Sussex, putting 371 jobs

US healthcare company Endo Health Solutions has acquired Canada-based specialty pharma company Paladin Labs in a deal worth

Merck Serono and Israel’s Kadimastem have signed a Memorandum of Understanding (MOU) aimed at advancing the two companies’

Johnson & Johnson, plus its subsidiaries Janssen and Scios, have finalized previously disclosed settlement agreements with the US